94 related articles for article (PubMed ID: 16165112)
1. A comparison of Verotoxin B-subunit (Stx1B) and CD77 antibody to define germinal centre populations.
Bailey S; Mardell C; Wheatland L; Zola H; Macardle PJ
Cell Immunol; 2005; 236(1-2):167-70. PubMed ID: 16165112
[TBL] [Abstract][Full Text] [Related]
2. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
George T; Boyd B; Price M; Lingwood C; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
[TBL] [Abstract][Full Text] [Related]
3. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis.
Khine AA; Firtel M; Lingwood CA
J Cell Physiol; 1998 Aug; 176(2):281-92. PubMed ID: 9648915
[TBL] [Abstract][Full Text] [Related]
4. The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40.
McCloskey N; Pound JD; Holder MJ; Williams JM; Roberts LM; Lord JM; Gordon J
Eur J Immunol; 1999 Oct; 29(10):3236-44. PubMed ID: 10540335
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.
Caron G; Le Gallou S; Lamy T; Tarte K; Fest T
J Immunol; 2009 Jun; 182(12):7595-602. PubMed ID: 19494283
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin.
Gordon J; Challa A; Levens JM; Gregory CD; Williams JM; Armitage RJ; Cook JP; Roberts LM; Lord JM
Cell Death Differ; 2000 Sep; 7(9):785-94. PubMed ID: 11042673
[TBL] [Abstract][Full Text] [Related]
8. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
Maloney MD; Lingwood CA
J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adhesion mechanisms and surface protein expression in CD77-positive and CD77-negative Burkitt's lymphoma cells.
Jackson T; Van Exel C; Reagans K; Verret R; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1195-200. PubMed ID: 11838967
[TBL] [Abstract][Full Text] [Related]
10. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
[TBL] [Abstract][Full Text] [Related]
11. Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells.
Jarvis RM; Chamba A; Holder MJ; Challa A; Smith DC; Hodgkin MN; Lord JM; Gordon J
Biochem Biophys Res Commun; 2007 Apr; 355(4):944-9. PubMed ID: 17336267
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
13. Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells.
Schwartz-Albiez R; Dörken B; Möller P; Brodin NT; Monner DA; Kniep B
Int Immunol; 1990; 2(10):929-36. PubMed ID: 2078521
[TBL] [Abstract][Full Text] [Related]
14. Comparison of detection methods for cell surface globotriaosylceramide.
Kim M; Binnington B; Sakac D; Fernandes KR; Shi SP; Lingwood CA; Branch DR
J Immunol Methods; 2011 Aug; 371(1-2):48-60. PubMed ID: 21726561
[TBL] [Abstract][Full Text] [Related]
15. Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue.
Imai Y; Ishikawa T; Tanikawa T; Nakagami H; Maekawa T; Kurohane K
J Immunol Methods; 2005 Jul; 302(1-2):125-35. PubMed ID: 15992815
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of human germinal center B cells.
Butch AW; Nahm MH
Cell Immunol; 1992 Apr; 140(2):331-44. PubMed ID: 1544165
[TBL] [Abstract][Full Text] [Related]
17. The fate of human CD77+ germinal center B lymphocytes after rescue from apoptosis.
Mangeney M; Rousselet G; Taga S; Tursz T; Wiels J
Mol Immunol; 1995 Apr; 32(5):333-9. PubMed ID: 7537855
[TBL] [Abstract][Full Text] [Related]
18. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity.
Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T
Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600
[TBL] [Abstract][Full Text] [Related]
19. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue.
Kolar GR; Mehta D; Wilson PC; Capra JD
Scand J Immunol; 2006 Sep; 64(3):314-24. PubMed ID: 16918701
[TBL] [Abstract][Full Text] [Related]
20. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
